Prognostic value of [¹⁸F]FDG PET/CT in metastatic hormone-sensitive prostate cancer at initial diagnosis: a retrospective cohort study.

ABSTRACT:

Introduction

This retrospective study aimed to evaluate the prognostic value of [¹⁸F]FDG parameters in patients with visceral and bone metastatic hormone-sensitive prostate cancer (mHSPC).

Patients and methods

This analysis included the mHSPC patients who underwent [¹⁸F]FDG PET/CT at the initial diagnosis. Baseline characteristics were analyzed, and the uptake of [¹⁸F]FDG was quantified using SUV_max. Kaplan-Meier and Cox proportional hazard regression analysis were employed to evaluate the correlation between SUV_max and patient survival.

Results

Among the 267 patients enrolled, 90 (33.7%) presented with visceral metastases and 177 (66.3%) had bone metastases. The median follow-up for the visceral metastasis group

SUBMITTER: Li A 

PROVIDER: S-EPMC11485890 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature